Cronos Group Inc (CRON)
$7.30 0.48 (7.04%)
19:59 EST CRON Stock Quote Delayed 15 Minutes
Previous Close $7.30
Market Cap 1.29B
PE Ratio -
Volume (Avg. Vol.) 7.50M
Day's Range 6.81 - 7.33
52-Week Range 6.04 - 25.10
Dividend & Yield N/A (N/A)
CRON Stock Predictions, Articles, and Cronos Group Inc News
- From InvestorPlace
- From the Web
By Thomas Niel
This makes it tough for average investors to win with Cronos stock. On the other hand, high-short interest may mean its too late to go short CRON. The company's shares could rally in a short squeeze scenario. So what's your play with Cronos stock? Avoid!
Some believe that Cronos stock overvalued. But if you consider cash on the balance sheet, CRON stock is more than reasonable.
Although recreational weed captures headlines, the real money is on broadly accepted medicinal marijuana stocks.
Like many other high quality pot stocks, CRON stock will eventually rebound from this sell-off, but not here, and not now.
Cronos stock is severely overvalued and is likely to fall further. Cronos is more expensive than any other Canadian cannabis stock, even despite the recent Altria investment
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
Options trading was hot in Intel, Tesla and Cronos Group stocks on Thursday. Here’s what the data suggests moving forward.
By David Moadel
CRON stock is not for the faint of heart. Do you think you have what it takes to profit from this pot powerhouse?
Options trading was buzzing in Cronos Group, Netflix and Disney on Thursday. Here are the metrics that matter moving forward.
Cronos Australia could help lend some credibility to Cronos Group, but it appears too small to significantly affect CRON stock.
While I believe that regulators will ultimately get this entire health scare sorted and both Juul and Cronos will go back to running their businesses, I can’t help but think how relieved Altria’s management must be that they made the $1.8 billion investment in Cronos in exchange for 45% of its stock.
Health impact of vaping makes CRON stock a concern from a regulatory and growth perspective. Keep it on the investment radar, but shares aren't likely to trend higher anytime soon.
Cannabis stocks were torched Thursday, while trade talks continue. Here's what happened in the stock market today.
Freeport-McMoRan, Coupa, Hexo, Cronos Group and Aphria were our top stock trades to watch on Thursday, as trade talks continue.
If understood and used correctly, technical analysis of marijuana stocks can allow you to identify important levels and trends -- and profit.
CRON stock continues to plunge, and with near-term profits unlikely and valuation still high, the declines may well continue.
Hysteria over the vaping crisis has hurt CRON stock. But investors should have patience until all the facts are straightened out.
These companies dole out a ton of stock as employee compensation, and that may be contributing to overvalued stocks.
From Market News Video
Investors in Cronos Group Inc (CRON) saw new options become available today, for the January 2020 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRON options chain for the new January 2020 contracts and identified one put and one call contract of particular interest.
Navellier RatingsPowered by Portfolio Grader